Actively Recruiting
Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital
Led by University Hospital, Strasbourg, France · Updated on 2025-12-24
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Neuroendocrine tumors are a diverse group of tumors, with gastrointestinal (gastroenteropancreatic) NETs being the most common. These tumors are usually well-differentiated and slow-growing, often associated with a median overall survival of up to 9 years. Managing these tumors involves controlling symptoms and tumor growth, using treatments like surgery, systemic therapies, and targeted radiotherapy. Nutritional status may influence the prognosis and quality of life in patients with these tumors, and this study explores that potential link. This observational study follows adult patients aged 18 to 70 years who are monitored for digestive neuroendocrine tumors diagnosed between 2000 and 2024. The research focuses on assessing patients' nutritional status and its association with their prognosis. It tracks the proportion of patients experiencing malnutrition over a period of up to 12 months. Participants will be observed during routine care without additional interventions, with data collected on their nutritional health and tumor status. Researchers will measure malnutrition rates and analyze how nutritional factors relate to patient outcomes. The study will continue until February 2026, aiming to provide insights that could improve the support and treatment strategies for patients with gastroenteropancreatic NETs.
CONDITIONS
Brief Title
Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 70 years
- Patients being monitored for a digestive neuroendocrine tumor (gastric, pancreatic, intestinal)
- Diagnosis made between January 1, 2000, and November 30, 2024
You will not qualify if you...
- Tumor reclassified as non-neuroendocrine by histopathology
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants with gastroenteropancreatic neuroendocrine tumors are observed to assess their nutritional status over time.
Visits as determined by routine clinical follow-up
Trial Site Locations
Total: 1 location
1
Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
P
Philippe BALTZINGER, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here